Effect of therapeutic levels of doxycycline and minocycline in the proliferation and differentiation of human bone marrow osteoblastic cells

Archives of Oral Biology

Volumn 52, Issue 3, 2007, Pages 251-259

  Gomes, Pedro Sousa ^a   Fernandes, Maria Helena ^a  

^a Universidade do Porto   (Portugal)

Author keywords

Doxycycline; Human bone marrow osteoblastic cells; Minocycline; Osteoblast differentiation; Osteoblast proliferation

Indexed keywords

ALKALINE PHOSPHATASE; ANTIINFECTIVE AGENT; CALCIUM; DOXYCYCLINE; MINOCYCLINE; PHOSPHORUS;

ARTICLE; BONE MARROW CELL; BONE MINERALIZATION; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; EXTRACELLULAR MATRIX; HUMAN; METABOLISM; METHODOLOGY; OSTEOBLAST; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ALKALINE PHOSPHATASE; ANTI-BACTERIAL AGENTS; BONE MARROW CELLS; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; EXTRACELLULAR MATRIX; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MINOCYCLINE; OSTEOBLASTS; PHOSPHORUS;

EID: 33846215617     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2006.10.005     Document Type: Article

References (51)

1. Salvi G., and Lang N. Host response modulation in the management of periodontal diseases. J Clin Periodontol 32 Suppl 6 (2005) 108-129
2. Page R., and Kornman K. The pathogenesis of human periodontitis: an introduction. Periodontology 2000 14 (1997) 9-11
3. Page R., Offenbacher S., Schroeder H., Seymour G., and Kornman K. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontology 2000 14 (1997) 216-248
4. Golub L., Wolff M., Roberts S., Lee H.-M., Leung M., and Payonk G. Treating periodontal diseases by blocking tissue-destructive enzymes. JADA 125 (1994) 163-169
5. Yoon S., Park S., Yun C., and Chung A. Role of matrix metalloproteinases in tumor metastasis and angiogenesis. J Biochem Mol Biol 36 (2003) 128-138
6. Mercado F., Marshall R., and Bartold P. Inter-relationship between rheumatoid arthritis and periodontal disease. J Clin Periodontol 30 (2003) 761-772
7. Service R. Tissue engineers build new bone. Science 289 (2000) 1497-1500
8. Golub L., Lee H.-M., Lehrer G., Nemiroff A., McNamara T., Kaplan R., et al. Minocycline reduces gingival collagenolytic activity during diabetes: preliminary observations and a proposed new mechanism of action. J Periodontal Res 18 (1983) 516-526
9. Vernillo A., Ramamurthy N., Golub L., and Rifkin B. The non-antimicrobial properties of tetracycline for the treatment of periodontal disease. Curr Opin Periodontol (1994) 111-118
10. Polson A., Novack M., and Ryan M. Effect of combination Periostat, Atridox, and SRP on surgical needs. J Dental Res 84 (2005) 2631 [abstract]
11. Polson A., Sharkey D., and Polson A. Use of systemic host modulation and locally applied antimicrobial in periodontal disease. J Appl Res Clin Dentist 2 (2005) 1-9
12. Novak M., Drisko C., and Magnusson I. Combination therapy with Periostat, Atridox, and scaling and root planing. J Dental Res 85 (2005) 2630 [abstract]
13. Ramamurthy N., Greenwald R., Celiker M., and Shi E. Experimental arthritis in rats induces biomarkers of periodontitis which are ameliorated by gene therapy with tissue inhibitor of matrix metalloproteinases. J Periodontol 76 (2005) 229-233
14. Williams S., Wakisaka A., Zeng Q., Barnes J., Seyedin S., Martin G., et al. Effect of minocycline on osteoporosis. Adv Dental Res 12 (1998) 71-75
15. Golub L., Ramamurthy N., Kaneko H., Sasaki T., Rifkin B., and McNamara T. Tetracycline administration prevents diabetes-induced osteopenia in the rat: initial observations. Res Commun Chem Pathol Pharmacol 68 (1990) 27
16. Sasaki T., Kaneko H., Ramamurthy N., and Golub L. Tetracycline administration restores osteoblasts strucutre and function during experimental diabetes. Anatom Record 231 (1991) 25-34
17. Yu Z., Ramamurthy N., Leung M., Chang K., McNamara T., and Golub L. Chemically-modified tetracycline normalises collagen metabolism in diabetic rats: a dose-response study. J Periodontal Res 28 (1993) 420-428
18. Bain S., Ramamurthy N., Impeduglia T., Scolman S., Golub L., and Rubin C. Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats. Bone 21 (1997) 147-153
19. Shlopov B., Smith Jr. G., Cole A., and Hasty K. Differential patterns of response to doxycycline and transforming growth factor β1 in the down-regulation of collagenases in osteoarthritic and normal human chondrocytes. Arthritis Rheumatism 42 (1999) 719-727
20. Orth M., Chlenbek K., Cole A., and Schmid T. Tetracycline derivates inhibit cartilage degradation in cultured embryonic chick tibiae. Res Veterin Sci 63 (1997) 11-14
21. Steinmeyer J., Daufeldt S., and Taiwo Y. Pharmacological effect of tetracyclines on proteoglycanases from interleukin-1-treated articular cartilage. Biochem Pharmacol 55 (1998) 93-100
22. Pytlik M., Folwarczna J., and Janiec W. Effects of doxycycline on mechanical properties of bones in rats with ovariectomy-induced osteopenia. Calc Tissue Int 75 (2004) 225-230
23. Polson A., Bouwsma O., McNamara T., and Golub L. Enhancement of alveolar bone formation after tetracycline administration in squirrel monkeys. J Appl Res Clin Dentist (2005) 32-42
24. Garlet G., Martins J.R.W., Fonseca B., Ferreira B., and Silva J. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 31 (2004) 671-679
25. Lynch M., Stein J., Stein G., and Lian J. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion and extracellular matrix mineralisation. Exp Cell Res 216 (1995) 35-40
26. Stein G., and Lian J. Molecular mechanisms mediated proliferation-differentiation interrelationships during progressive development of the osteoblast phenotype: update. Eur Rev 4 (1995) 290-297
27. Rowe D., Ko S., Tom X., Silverstein S., and Richards D. Enhanced production of mineralised nodules and collagenous proteins in vitro by calcium ascorbate supplemented with vitamin C metabolites. J Periodontol 70 (1999) 992-999
28. Abe T., Abe Y., Aida Y., Hara Y., and Maeda K. Extracellular matrix regulates induction of alkaline phosphatase expression by ascorbic acid in human fibroblasts. J Cell Physiol 189 (2001) 144-151
29. Shiga M., Kapila Y., Zhang Q., Hayami T., and Kapila S. Ascorbic acid induces collagenase-1 in human periodontal ligament cells but not in MC3T3-E1 osteoblast-like cells: potential association between collagenase expression and changes in alkaline phosphatase phenotype. J Bone Miner Res 18 (2003) 67-91
30. Geoffroy V., Marty-Morieux C., Goupil N., Clement- Lacroix P., Terraz C., Frain M., et al. In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass. J Bone Miner Res 19 (2004) 811-822
31. Bellows C., Aubin J., and Heersche J. Initiation and progression of mineralisation of bone nodules formed in vitro. The role of alkaline phosphatase and organic phosphate. Bone Miner 14 (1991) 27-40
32. Coelho M., and Fernandes M. Human bone cell cultures in biocompatibility testing. Part II. Effect of ascorbic acid, β-glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials 21 (2000) 1095-1102
33. Sande M., and Mandell G. Tetracyclines, chloramphenicol, erytromycin and miscellaneous antibacterial agents. In: Gilman A., Goodman L., Rall T., and Murad F. (Eds). The Pharmacological Basis of Therapeutics (1985), Macmillan 1170-1198
34. Sakellari D., Goodson J., Socransky S., Kolokotronis A., and Konstantinidis A. Concentration of 3 tetracyclines in plasma, gingival crevice fluid and saliva. J Clin Periodontol 27 (2000) 53-60
35. Caton J. Evaluation of Periostat for patient management. Compend Cont Educ Dentist 20 (1999) 451-456
36. Williams S., Wakisaka A., Zeng Q., Barnes J., Martin G., and Wechter W. Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomised aged rats. Bone 19 (1996) 637-644
37. Schwartz Z., Lohmann C., Wieland M., Cochran D., Dean D., Textor M., et al. Osteoblast proliferation and differentiation on dentin slices are modulated by pretreatment of the surface with tetracycline or osteoclasts. J Periodontol 71 (2000) 586-597
38. Holmes S., Still K., Buttle D., Bishop N., and Grbowski P. Chemically modified tetracyclines act through multiple mechnisms directly on osteoclast precursors. Bone 35 (2004) 471-478
39. Li Q.-N., Hu B., Huang L.-F., Chen Y., Weng L.-L., Zheng H., et al. Effects of low doses of hydrochloride tetracycline on bone metabolism and uterus in ovariectomised rats. Acta Pharmacol Sinica 24 (2003) 599-604
40. Kirkwood K., Martin T., Andreadis S., and Kim Y. Chemically modified tetracyclines selectively inhibit IL-6 expression in osteoblasts by decreasing mRNA stability. Biochem Pharmacol 66 (2003) 1809-1819
41. Kirkwood K, Golub L, Bradford P. Non-antimicrobial and antimicrobial tetracyclines inhibit IL expression in murine osteoblasts. Ann NY Acad Sci 667-70.
42. Golub L., Lee H.-M., and Ryan M. Tetracyclines inhibit connective-tissue breack-down by multiple non-antimicrobial mechanisms. Adv Dental Res 12 (1998) 12-26
43. Karimbux N., Ramamurthy N., Golub L., and Nishimura I. The expression of collagen I and XII on RNAs in porphyromonas gingivalis-induced periodontitis in rats. The effect of doxycycline and chemically modified tetracycline (CMT-1). J Periodontol 69 (1998) 39-40
44. Ramamurthy N., Pirila E., and Lee H.-M. Delayed wound healing, altered collagen level and keratinocyte growth factor expression in skin of ovariectomised rat is normalised by estrogen or chemically modified doxycycline. In: Schneider H. (Ed). Menopause-The Sate of the Art in Research and Management, The Proceedings of the 10th World Congress (2003), Parthenon Publishing Group, New York 236-243
45. Craig R., Yu Z., and Xu L. A chemically modified tetracycline inhibits streptozotocin-induced diabetes depression of skin collagen synthesis and steady-state type I procollagen mRNA. Biochim Biophys Acta 1402 (1998) 250-260
46. Salasznyk R., Williams W., Boskey A., Batorsky A., and Plopper G. Adhesion to vitronectin and collagen i promotes osteogenic differentiation of human mesenchymal stem cells. J Biomed Biotechnol 1 (2004) 24-34
47. Gerstenfeld L., Chipman S., Kelly C., Hodgens K., Lee D., and Landis W. Collagen expression, ultrastructural assembly, and mineralisation in cultures of chicken embryo osteoblasts. J Cell Biol 106 (1988) 979-989
48. Pornprasertsuk S., Duarte W., Mochida Y., and Yamauchi M. Overexpression of lysyl hydroxylase-2b leads to defective collagen fibrillogenesis and matrix mineralisation. J Bone Miner Res 20 (2005) 81-87
49. Murshed M., Schinke T., McKee M., and Karsenty G. Extracellular matrix mineralisation is regulated locally;different roles of two gla-containing proteins. J Cell Biol 165 (2004) 625-630
50. Dvorak M., Siddiqua A., Ward D., Carter D., Dallas S., Nemeth E., et al. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. PNAS 101 (2004) 5140-5145
51. Quarles L. Cation sensing receptor in bone: a novel paradigm for regulating bone remodeling?. J Bone Miner Res 12 (1997) 1971-1974